Literature DB >> 31690125

Expression of Cyp2c/Cyp2j subfamily members and oxylipin levels during LPS-induced inflammation and resolution in mice.

Joan P Graves1, J Alyce Bradbury1, Artiom Gruzdev1, Hong Li1, Caroline Duval1, Fred B Lih1, Matthew L Edin1, Darryl C Zeldin1.   

Abstract

Inflammatory stimuli, such as bacterial LPS, alter the expression of many cytochromes P450. CYP2C and CYP2J subfamily members actively metabolize fatty acids to bioactive eicosanoids, which exhibit potent anti-inflammatory effects. Herein, we examined mRNA levels of the 15 mouse Cyp2c and 7 mouse Cyp2j isoforms in liver, kidney, duodenum, and brain over a 96-h time course of LPS-induced inflammation and resolution. Plasma and liver eicosanoid levels were also measured by liquid chromatography with tandem mass spectrometry. Expression changes in Cyp2c and Cyp2j isoforms were both isoform and tissue specific. Total liver Cyp2c and Cyp2j mRNA content was reduced by 80% 24 h after LPS but recovered to baseline levels by 96 h. Total Cyp2c and Cyp2j mRNA in kidney (-19%) and duodenum (-64%) were reduced 24 h after LPS but recovered above baseline by 72 h. Total Cyp2c and Cyp2j mRNA content in brain was elevated at all time points after LPS dosing. Plasma eicosanoids transiently increased 3-6 h after administration of LPS. In liver, esterified oxylipin levels decreased during acute inflammation and before recovering. The biphasic suppression and recovery of mouse Cyp2c and Cyp2j isoforms and associated changes in eicosanoid levels during LPS-induced inflammation and resolution may have important physiologic consequences.-Graves, J. P., Bradbury, J. A., Gruzdev, A., Li, H., Duval, C., Lih, F. B., Edin, M. L., Zeldin, D. C. Expression of Cyp2c/Cyp2j subfamily members and oxylipin levels during LPS-induced inflammation and resolution in mice.

Entities:  

Keywords:  cytochromes P450; eicosanoids; fatty acids; gene expression; ipopolysaccharide

Mesh:

Substances:

Year:  2019        PMID: 31690125      PMCID: PMC6894073          DOI: 10.1096/fj.201901872R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.834


  44 in total

1.  Soluble epoxide hydrolase is a therapeutic target for acute inflammation.

Authors:  Kara R Schmelzer; Lukas Kubala; John W Newman; In-Hae Kim; Jason P Eiserich; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-30       Impact factor: 11.205

2.  Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids.

Authors:  Cosima Arnold; Marija Markovic; Katrin Blossey; Gerd Wallukat; Robert Fischer; Ralf Dechend; Anne Konkel; Clemens von Schacky; Friedrich C Luft; Dominik N Muller; Michael Rothe; Wolf-Hagen Schunck
Journal:  J Biol Chem       Date:  2010-08-23       Impact factor: 5.157

Review 3.  Regulation of cytochrome p450 by inflammatory mediators: why and how?

Authors:  E T Morgan
Journal:  Drug Metab Dispos       Date:  2001-03       Impact factor: 3.922

Review 4.  Regulation of cytochromes P450 during inflammation and infection.

Authors:  E T Morgan
Journal:  Drug Metab Rev       Date:  1997-11       Impact factor: 4.518

5.  TLR-4 mediated group IVA phospholipase A(2) activation is phosphatidic acid phosphohydrolase 1 and protein kinase C dependent.

Authors:  Andrej Grkovich; Aaron Armando; Oswald Quehenberger; Edward A Dennis
Journal:  Biochim Biophys Acta       Date:  2009-02-20

Review 6.  LPS/TLR4 signal transduction pathway.

Authors:  Yong-Chen Lu; Wen-Chen Yeh; Pamela S Ohashi
Journal:  Cytokine       Date:  2008-03-04       Impact factor: 3.861

Review 7.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Authors:  John D Imig; Bruce D Hammock
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

8.  Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism.

Authors:  Katherine N Theken; Yangmei Deng; M Alison Kannon; Tricia M Miller; Samuel M Poloyac; Craig R Lee
Journal:  Drug Metab Dispos       Date:  2010-10-14       Impact factor: 3.922

9.  Gene and protein expression and cellular localisation of cytochrome P450 enzymes of the 1A, 2A, 2C, 2D and 2E subfamilies in equine intestine and liver.

Authors:  Eva Tydén; Hans Tjälve; Pia Larsson
Journal:  Acta Vet Scand       Date:  2014-10-08       Impact factor: 1.695

10.  Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model.

Authors:  Caroline Duval; Fatima Teixeira-Clerc; Alix F Leblanc; Sothea Touch; Claude Emond; Michèle Guerre-Millo; Sophie Lotersztajn; Robert Barouki; Martine Aggerbeck; Xavier Coumoul
Journal:  Environ Health Perspect       Date:  2016-10-07       Impact factor: 9.031

View more
  2 in total

1.  Cardiomyocyte-specific disruption of soluble epoxide hydrolase limits inflammation to preserve cardiac function.

Authors:  Deanna K Sosnowski; K Lockhart Jamieson; Artiom Gruzdev; Yingxi Li; Robert Valencia; Ala Yousef; Zamaneh Kassiri; Darryl C Zeldin; John M Seubert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-19       Impact factor: 5.125

2.  Monolayer autoxidation of arachidonic acid to epoxyeicosatrienoic acids as a model of their potential formation in cell membranes.

Authors:  James A Weiny; William E Boeglin; M Wade Calcutt; Donald F Stec; Alan R Brash
Journal:  J Lipid Res       Date:  2021-12-02       Impact factor: 5.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.